JOSEFA Y ASUNCIÓN [Material gráfico]

ÁLBUM FAMILIAR CASA DE COLÓNCopia digital. Madrid : Ministerio de Educación, Cultura y Deporte. Subdirección General de Coordinación Bibliotecaria, 201

Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin

TMEM45A is a transmembrane protein involved in tumor progression and cancer resistance to chemotherapeutic agents in hypoxic condition. It is correlated to a low breast cancer patient overall survival. However, little is known about this protein, in particular the mechanisms by which TMEM45A modulates cancer cell chemosensitivity. In this work, the messenger RNA expression of TMEM45A was assessed in head and neck squamous cell carcinoma (HNSCC) and renal cell carcinoma (RCC) biopsies. TMEM45A was upregulated in patients diagnosed for head and neck or renal cancer. Then, the implication of this protein in cisplatin sensitivity was explored in SQD9 and RCC4 + pVHL cells. TMEM45A inactivation decreased cell proliferation and modulated cell responses to cisplatin. Indeed, TMEM45A inactivation increased the sensitivity of SQD9 cells to cisplatin, whereas it rendered RCC4 + pVHL cells resistant to this anticancer agent. Through RNA-sequencing analysis, we identified several deregulated pathways that indicated that the impact on cisplatin sensitivity may be associated to the inhibition of DNA damage repair and to UPR pathway activation. This study demonstrated, for the first time, an anti or a pro-apoptotic role of this protein depending on the cancer type and highlighted the role of TMEM45A in modulating patient responses to treatment

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis

UNLABELLED Low hypodiploidy defines a rare subtype of B-cell acute lymphoblastic leukemia (B-ALL) with a dismal outcome. To investigate the genomic basis of low-hypodiploid ALL (LH-ALL) in adults, we analyzed copy-number aberrations, loss of heterozygosity, mutations, and cytogenetics data in a prospective cohort of Philadelphia (Ph)-negative B-ALL patients (n = 591, ages 18-84 years), allowing us to identify 80 LH-ALL cases (14%). Genomic analysis was critical for evidencing low hypodiploidy in many cases missed by cytogenetics. The proportion of LH-ALL within Ph-negative B-ALL dramatically increased with age, from 3% in the youngest patients (under 40 years old) to 32% in the oldest (over 55 years old). Somatic TP53 biallelic inactivation was the hallmark of adult LH-ALL, present in virtually all cases (98%). Strikingly, we detected TP53 mutations in posttreatment remission samples in 34% of patients. Single-cell proteogenomics of diagnosis and remission bone marrow samples evidenced a preleukemic, multilineage, TP53-mutant clone, reminiscent of age-related clonal hematopoiesis. SIGNIFICANCE We show that low-hypodiploid ALL is a frequent entity within B-ALL in older adults, relying on somatic TP53 biallelic alteration. Our study unveils a link between aging and low-hypodiploid ALL, with TP53-mutant clonal hematopoiesis representing a preleukemic reservoir that can give rise to aneuploidy and B-ALL. See related commentary by Saiki and Ogawa, p. 102. This article is highlighted in the In This Issue feature, p. 101

New ruthenium complexes associated to Secondary Phosphine Oxides (SPO) : Synthesis, characterisation and application in catalysis

Depuis le début des années 2000, les Oxydes de Phosphine Secondaire (OPS) connaissent un regain d'intérêt en catalyse comme préligands des métaux de transitions. Alors que de nombreux complexes organométalliques associés à des OPS ont été préparés, caractérisés et utilisés en catalyse homogène, les complexes correspondant du ruthénium sont plus rares.Nous nous sommes intéressés à la synthèse et la caractérisation de nouveaux complexes de ruthénium(II) comportant un (ou plusieurs) ligand acide phosphineux (AP) (forme tautomère d'un OPS) puis au rôle du ligand dans un cycle catalytique. Le traitement de différentes sources de ruthénium par des OPS a permis d'isoler des séries de complexes de ruthénium [Ru]/OPS (coordination par l'oxygène) et [Ru]/AP (coordination par le phosphore). L'activité catalytique de ces complexes bien définis a été étudiée dans des réactions d'activation de liaisons C-H et de cycloisomérisation à partir d'alcynes ou d'ynamides. Lors de ces études, il a été montré l'influence des paramètres stéréoélectroniques du ligand lié au ruthénium au cours du processus catalytique.En marge de ces travaux, dans la continuité de notre intérêt pour la réactivité des ynamides, nous avons développé une nouvelle réactivité des ynamides avec les 1,3-dicétones cycliques catalysée au ruthénium, à l'or ou au palladium pour la synthèse d'alpha-alcoxy-énamides.The past decade has witnessed a renewed interest for Secondary Phosphine Oxides (SPO) in catalysis as preligands of transition metals. While the coordination chemistry and catalytic activity of these species have been mainly studied with palladium and platinum, only few examples with ruthenium have been reported so far.We investigated the synthesis of new ruthenium(II) complexes associated to one or two phosphinous acid ligand (PA) (SPO tautomer) which were fully characterised. Then we were interested in the role played by the ligand during the catalytic cycle. The use of different ruthenium sources allowed us to isolate [Ru]/SPO complexes (oxygen coordinated) and [Ru]/PA complexes (phosphorous coordinated). We evaluated the catalytic activities of these well-defined complexes in C-H bond activation and cycloisomerisation from alkynes or ynamides. During the course of these studies, the influence of ligand stereoelectronic parameters in the catalytic process have been demonstrated.Moreover, in a side project, we explored a new reactivity of ynamides with cyclic 1,3-diketones catalysed by palladium, cationic gold or ruthenium complexes. This reactivity gives access to alpha-alkoxysubstituted enamides

Highly Selective Syn Addition of 1,3-Diones to Internal Ynamides Catalyzed by Zinc Iodide

International audienceHaving previously established that 1,3-diones could be used as nucleophiles to perform additions to ynamides, highly selective hydroalkoxylation of internal ynamides is now described herein. Several catalytic systems were compared to carry out this transformation including transition metal-based catalysts or Lewis acids. ZnI2 was found to be both very active and highly selective giving only E adducts through a syn addition. Scope and limits investigation showed that this catalyst was compatible with various functional groups. In addition to 17 examples of ynamide hydroalkoxylation, one example of ynamide hydroarylation is reported

Palladium-Catalyzed Addition of 1,3-Diones to Ynamides: An Entry to Alkoxy-Substituted Enamides

International audienceA new metal-catalyzed addition reaction of 1,3-diketones to ynamides, which provides access to unprecedented alkoxy- substituted enamides, is disclosed herein. A screening of cata- lytic systems showed that both a phosphapalladacycle and a cationic gold complex were capable of promoting this reac- tion rapidly and cleanly. The scope investigation revealed that variously substituted terminal ynamides and cyclic 1,3-diones were well tolerated. The use of internal ynamides led to the formation of both E and Z isomers with low to good selectivi- ties. The proposed mechanism suggests that the phosphapalla- dacycle acts as a p Lewis acid to activate the ynamide

Ruthenium Carbonyl Complexes Bearing Secondary Phosphine Oxides and Phosphinous Acids: Synthesis, Characterization, and Application in Catalysis

International audienceTwo series of ruthenium carbonyl complexes bearing either one secondary phosphine oxide ligand or two phosphinous acids have been synthesized and characterized. The catalytic behavior of these complexes has been then investigated for the cycloisomerization of arenynes. This study highlighted a strong relationship between ligands’ and substrates’ substructures